Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 3 18Phase 1/2 3Phase 1 3Phase 2/3 2Phase NA 1Phase 4 1

Status

Completed 174Terminated 49Recruiting 16Unknown 12Withdrawn 11Active not recruiting 11Not yet recruiting 3Suspended 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Other solid neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasm Metastasis 1Advanced Solid Tumors 1Adenocarcinoma 1

Interventions

Cyclophosphamide 22fludarabine 17Specimen Handling 13Nivolumab 10pembrolizumab 9Magnetic Resonance Spectroscopy 9Radiotherapy 6Cisplatin 6fludarabine phosphate 5Interleukin-2 5Injections 5Doxorubicin 5tislelizumab 4daratumumab 4Paclitaxel 4Ipilimumab 4Immune Checkpoint Inhibitors 4Drug Therapy 4Dexamethasone 4Carboplatin 4Biopsy 4venetoclax 3trastuzumab deruxtecan 3toripalimab 3ruxolitinib 3X-Rays 3Vincristine 3Rituximab 3Radiosurgery 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Docetaxel × Clear all
NCT07316686 2026-05-18

Lutécio

Instituto do Cancer do Estado de São Paulo

Phase 1 Not yet recruiting
18 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06724042 2025-12-10

Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors

InSilico Medicine Hong Kong Limited

Phase 1 Not yet recruiting
159 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06925659 2025-04-17

A Study of QLM2011 in Subjects With Advanced Solid Tumors

Qilu Pharmaceutical (Hainan) Co., Ltd.

Phase 1 Not yet recruiting
172 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡